1230 related articles for article (PubMed ID: 9278623)
1. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
2. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
[TBL] [Abstract][Full Text] [Related]
3. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
[TBL] [Abstract][Full Text] [Related]
4. Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma.
Maddison P; Newsom-Davis J; Mills KR; Souhami RL
Lancet; 1999 Jan; 353(9147):117-8. PubMed ID: 10023900
[No Abstract] [Full Text] [Related]
5. [A case of small cell carcinoma of the lung associated with paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome].
Seki N; Mitsui J; Hoshino M; Akishiro M; Ugawa Y; Goto J; Tsuji S
No To Shinkei; 2006 Jan; 58(1):68-73. PubMed ID: 16482925
[TBL] [Abstract][Full Text] [Related]
6. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
Iwanami M; Odaka M; Nakamura T; Hirata K
Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
[TBL] [Abstract][Full Text] [Related]
7. [Paraneoplastic Cerebellar Degeneration with Lambert-Eaton Myasthenic Syndrome: A Report of an Effectively Treated Case and Systematic Review of Japanese Cases].
Kitanosono H; Motomura M; Tomita H; Iwanaga H; Iwanaga N; Irioka T; Shiraishi H; Tsujino A
Brain Nerve; 2019 Feb; 71(2):167-174. PubMed ID: 30718446
[TBL] [Abstract][Full Text] [Related]
8. GRP78 antibodies damage the blood-brain barrier and relate to cerebellar degeneration in Lambert-Eaton myasthenic syndrome.
Shimizu F; Takeshita Y; Sano Y; Hamamoto Y; Shiraishi H; Sato T; Yoshimura S; Maeda T; Fujikawa S; Nishihara H; Kitanosono H; Tsujino A; Motomura M; Kanda T
Brain; 2019 Aug; 142(8):2253-2264. PubMed ID: 31236596
[TBL] [Abstract][Full Text] [Related]
9. Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
Motomura M; Lang B; Johnston I; Palace J; Vincent A; Newsom-Davis J
J Neurol Sci; 1997 Mar; 147(1):35-42. PubMed ID: 9094058
[TBL] [Abstract][Full Text] [Related]
10. P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system.
Voltz R; Carpentier AF; Rosenfeld MR; Posner JB; Dalmau J
Muscle Nerve; 1999 Jan; 22(1):119-22. PubMed ID: 9883867
[TBL] [Abstract][Full Text] [Related]
11. P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer.
Graus F; Lang B; Pozo-Rosich P; Saiz A; Casamitjana R; Vincent A
Neurology; 2002 Sep; 59(5):764-6. PubMed ID: 12221175
[TBL] [Abstract][Full Text] [Related]
12. [Report of a case of small cell lung cancer associated with Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration--with a review of the Japanese literature].
Ohkubo K; Ohishi K; Motomura M; Sakai K; Tsujihata M; Nagataki S
No To Shinkei; 1994 Mar; 46(3):285-9. PubMed ID: 8192944
[TBL] [Abstract][Full Text] [Related]
13. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
Titulaer MJ; Lang B; Verschuuren JJ
Lancet Neurol; 2011 Dec; 10(12):1098-107. PubMed ID: 22094130
[TBL] [Abstract][Full Text] [Related]
14. [Synchronous appearance and improvement with anticancer chemotherapy of paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome complicated with small cell lung cancer].
Koriyama H; Kyoraku I; Yamashita S; Shiomi K; Matsumoto N; Nakazato M
Rinsho Shinkeigaku; 2013; 53(2):104-8. PubMed ID: 23470889
[TBL] [Abstract][Full Text] [Related]
15. Conjoint occurrence of GABAB receptor antibodies in Lambert-Eaton myasthenic syndrome with antibodies to the voltage gated calcium channel.
Dogan Onugoren M; Rauschka H; Bien CG
J Neuroimmunol; 2014 Aug; 273(1-2):115-6. PubMed ID: 24929678
[TBL] [Abstract][Full Text] [Related]
16. Absence of anti-P/Q calcium channel antibody in the sera of patients with anti-Yo antibody-positive paraneoplastic cerebellar degeneration.
Tanaka K; Motomura M; Nakao Y; Tanaka M; Tsuji S
Neurology; 1997 Sep; 49(3):895-6. PubMed ID: 9305368
[No Abstract] [Full Text] [Related]
17. Paraneoplastic cerebellar degeneration and lambert-eaton myasthenia in a patient with merkel cell carcinoma and voltage-gated calcium channel antibodies.
Pavolucci L; Giannini G; Giannoccaro MP; Foschini MP; Lang B; Avoni P; Tinuper P; Vincent A; Liguori R
Muscle Nerve; 2017 Nov; 56(5):998-1000. PubMed ID: 28006860
[TBL] [Abstract][Full Text] [Related]
18. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
Kitanosono H; Shiraishi H; Motomura M
Brain Nerve; 2018 Apr; 70(4):341-355. PubMed ID: 29632282
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome.
Clouston PD; Saper CB; Arbizu T; Johnston I; Lang B; Newsom-Davis J; Posner JB
Neurology; 1992 Oct; 42(10):1944-50. PubMed ID: 1407577
[TBL] [Abstract][Full Text] [Related]
20. Coexistence of paraneoplastic sensory neuronopathy and Lambert-Eaton myasthenic syndrome in a small cell lung cancer patient.
Kawahara M; Furuse K; Kodama N; Ogawara M; Kubota K; Yamamoto S; Tada H; Mori T; Miyawaki Y; Hirohashi S
Jpn J Clin Oncol; 1994 Aug; 24(4):224-7. PubMed ID: 8072202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]